Malignant mesothelioma is one of the very few extrarenal neoplasms in which the Wilms tumor suppressor gene (wt1) is expressed. We examined wt1 for alterations in rat mesotheliomas, a well characterized animal model for the human disease. Southern analysis revealed a 3.5 kb EcoRI wt1 fragment readily detectable in majority of mesothelioma cell lines and primary mesotheliomas but not in normal rat tissues. Cloning and sequencing of this fragment revealed that the presence of this EcoRI fragment resulted from an inability of this enzyme to cut at a EcoRI site in intron 1 of wt1. This site contains potential motifs for cytosine methylation and treatment of mesothelioma cells with 5-azadeoxycytosine restored the normal EcoRI digestion pattern of wt1 in these cells indicating that cleavage was inhibited by methylation at this site. Southern analysis using HpaII/MspI digestion revealed no dierences in methylation between mesothelioma cell lines and normal mesothelium at other CpG sites in wt1 5' region. Renal cell carcinoma lines which did not express wt1 were also methylated at this EcoRI site. Our identi®cation of a site frequently methylated in malignant cells, independent of gene expression, provides a new model system to study determinants of site-speci®c methylation in tumors.
Introduction
DNA methylation has been proposed to be involved in adverse genetic alterations associated with neoplastic transformation Rainier and Feinberg, 1994; Jones, 1996) . The abnormal DNA methylation observed in tumors includes both loss and gain of methyl-groups at the C5 position of cytosine in CpG dinucleotides, which are targets for DNA methylation in mammalian cells. In the human genome, CpG sites are normally heavily methylated in adult tissues; however, there are speci®c CpG-rich regions that are unmethylated in these tissues. These CpG-rich regions are commonly found in the 5' regulatory domains of genes and are believed to de®ne an`open' chromatin conformation and active state for these genes when unmethylated and a condensed chromatin structure which is`inactive' when methylated. Gene silencing via DNA methylation has been shown for several tumor suppressor genes, such as retinoblastoma gene in retinoblastomas (Ohtani-Fujita et al., 1993) , von Hippel-Lindau gene in renal cell carcinomas and p16 in epithelial cancers (Merlo et al., 1995) . In tumor cells de novo DNA methylation is proposed to occur as a result of increased activity of DNA methyltransferase (elDeiry et al., 1991) , an enzyme thought to be responsible for maintenace and de novo DNA methylation in mammals. However, the molecular determinants of DNA methylation at speci®c CpG sites in tumor cells are unknown at present.
The short arm of human chromosome 11, where the Wilms tumor suppressor gene (WT1) resides is known to contain methylated regions in both normal tissues and tumors (de Bustros et al., 1988) , and recently it was demonstrated that transcription of the H19 and insulin-like growth factor II (IGFII) genes, which reside on chromosome 11, is regulated by methylation (Li et al., 1993) . WT1, which encodes a zinc-®nger DNAbinding protein with properties of a transcription factor and a putative splicing regulator (Drummond et al., 1992; Larsson et al., 1995) , was identi®ed by its location in overlapping 11p13 deletions occurring in Wilms' tumors (Call et al., 1990; Gessler et al., 1990) . Wilms' tumor is an embryonic nephroblastoma which occurs in both familial and spontaneous forms (Francke et al., 1979; Fearon et al., 1984) . Loss of heterozygosity of the WT1 gene is a common ®nding in Wilms' tumors in addition to other alterations, including gross and small deletions, insertions, and point mutations (Cowell et al., 1991; Kikuchi et al., 1992; Little et al., 1992) . These data are consistent with Knudson and Strong's model of tumor suppressor gene function for the WT1 gene in Wilms' tumors (Knudson and Strong, 1972) . However, WT1 expression is observed in half of Wilms' tumors (although the biological meaning of this expression is unknown) and the low mutation frequency detected in sporadic tumors expressing WT1 suggests that genetic alterations other than inactivating mutations in WT1 may be involved in tumorigenesis.
In mice, knocking out wt1 has a striking eect on development of the mesothelium (Kreidberg et al., 1993) , and malignant mesothelioma (MM) is one of a very few extrarenal neoplasms that express WT1 (Miyagi et al., 1993; Park et al., 1993; Walker et al., 1994) . Development of MM in humans is closely associated with environmental or occupational exposure to asbestos or other carcinogenic mineral ®bers. This correlation was clearly established in the 1960s (Wagner et al., 1960) , but asbestos continues to be intensively mined and used, presenting signi®cant health risks for occupationally exposed workers. The incidence of MMs, which are rare tumors in the general population, continues to increase and in the United States about 2000 ± 3000 cases per year are expected until the end of the century (Antman et al., 1993) . Mesothelial cells, which like epithelial cells of the renal nephron originate from the mesoderm, are believed to be the progenitor cells for these tumors. Like epithelial cells of the renal nephron, mesothelial cells undergo a mesenchymal-epithelial transition in which the WT1 gene product has been shown to participate (Hastie, 1994) . The long latency period of MM (20 ± 40 years) suggests that multiple genetic alterations are necessary for the genesis of this disease, and recent studies revealed that the p16 and neuro®bromatosis 2 tumor suppressor genes are frequently damaged in human MMs (Cheng et al., 1994; Sekido et al., 1995; Bianchi et al., 1995; Xiao et al., 1995) . No mutations were found in WT1 coding region in one report which examined 32 asbestosassociated human mesotheliomas (Park et al., 1993) ; however, a detailed study of this gene in MM has not yet been conducted.
The rat is an important experimental model for studying mechanisms of mesothelioma development, and for testing the carcinogenic potential of mineral ®bers. Expression of the wt1 gene in rat mesotheliomas has been reported previously (Walker et al., 1994) , but no other information about the status of this gene in these tumors is available. We report here that consistent with human data, no mutations were found in wt1 exons 7 ± 10 encoding the DNA-binding domain of wt1 in rat MM cell lines. However, methylation of a CpG site in intron 1 of the wt1 gene was detected in the majority of MM cell lines and primary mesotheliomas analysed. In addition, methylation of this site was detected in rat renal cell carcinoma cell lines, which do not express wt1, suggesting that transformed cells become programmed to methylate this site and that this programming is driven by determinants other than gene expression.
Results
Mutations within the WT1 coding region, which are frequently detected in tumors, are believed to alter the ability of the WT1 protein to bind DNA and so may modify its putative tumor suppressor function. wt1 exons 7 ± 10, encoding the DNA-binding domain, in which most of these mutations occur, were examined for mutations in rat MM cell lines II45, II14, ME1T, NRM1, NRM2, NRM3, and NRM4 by direct sequencing of reverse transcription (RT) ± polymerase chain reaction (PCR) products ampli®ed using primers shown in Figure 1a . In addition, RT ± PCR fragments, which span exons 1 ± 7 were sequenced in the rat MM cell lines II45, II14 and NRM3. At least two independent RT ± PCR products for each cell line were sequenced in both directions. No mutations were detected in any of the regions analysed (data not shown).
To examine the wt1 gene for other structural alterations, we performed Southern analysis of genomic DNA digested with one of the restriction wt 1 Figure 1 Schematic representation of the rat wt1 gene (a) and the clone wk 1.4 (b). The shaded boxes represent wt1 exons (not drawn to scale). PrE -the intronic EcoRI site, protected from cleavage in MM. Potential CpG sites methylated in MM and ERC cell lines, are boxed. The horizontal arrows indicate the location and direction of primers used for PCR and sequencing. The vertical arrows indicate binding sites for transcriptional factors Ap2 (A), Sp1 (S), and GCN4 (G) and for histone H4 (H) wt1 site-specific methylation EV Kleymenova et al enzymes, EcoRI, BglII, PstI, PvuI, BamHI, HindIII, RsaI and HhaI, and hybridized with a 32 P-labeled RT ± PCR product spanning exons 1 ± 7 of rat wt1 gene. Of the 11 MM cell lines and ®ve asbestos-induced MM examined, 10 cell lines and four primary tumors had an additional 3.5 kb EcoRI fragment ( Figure 2 ) that was absent or only apparent as a very faint band in the DNA from normal rat tissues after prolonged (4 weeks) exposure (Figure 2 ). This 3.5 kb fragment was present at an approximately single copy level in the transformed mesothelial cells. Normal liver DNA from six other rat strains exhibited the same pattern as normal Fisher rat tissues, with only a faint 3.5 kb band observable after prolonged exposure ( Figure 3 ). Incomplete digestion did not account for the novel EcoRI band, as digestion with 6 ± 10 units of enzyme per mg of DNA gave the same pattern by Southern analysis as the standard digestion with 3 units/mg, which was sucient to digest completely control Lambda phage DNA (data not shown). Using probes speci®c for rat wt1 exons 1 ± 7, 4 ± 7, or 1 ± 3, the 3.5 kb band was shown to contain wt1 sequence homologous to exons 1 ± 3, and subsequent studies focused on this region.
To determine the nature of this novel band, the 3.5 kb EcoRI fragment from MM cell line II45 was cloned into the EcoRI site of Lambda ZAP II. The Lambda ZAP II library was screened with a probe to wt1 exons 1 ± 3, and clone wk 1.4 was chosen for pBluescript excision. Sequencing of wk 1.4 revealed that the clone contained only the 5' end of exon 2 of the rat wt1 gene. As expected, the 3.5 kb insert in wk 1.4 contained EcoRI sites at both ends, but it also had an internal EcoRI site 300 bp from the 3' end of this clone (100 bp from the 5' end of the exon 2, Figure  1b ), presumably in intron 1 of the rat wt1 gene. To con®rm that the sequence adjoining exon 2 containing this EcoRI site in clone wk 1.4 was present in the normal rat wt1 gene, we directly sequenced a PCR product ampli®ed from normal rat liver DNA using primers 4581 and r618 ( Figure 1a ). This PCR product spanned the rat wt1 gene from the 3' end of exon 1 to the 5' end of exon 3 and was con®rmed by DNA sequencing to contain the EcoRI site 100 bp upstream of exon 2 observed in clone wk 1.4 isolated from MM cell line II45.
The presence of this intronic EcoRI site 300 bp upstream of the EcoRI site in exon 2 predicted that a 300 bp fragment containing exon 2 should be released by EcoRI digestion of the normal rat wt1 gene. Southern analysis revealed that a 300 bp EcoRI fragment that hybridized to exon 2 of the wt1 gene was readily detectable only in normal rat tissues and the MM cell line II14 which did not have the extra 3.5 kb fragment (Figure 4) . The inverse correlation observed between the presence of the 3.5 kb and 300 bp EcoRI fragments suggested that the EcoRI site 100 bp upstream to exon 2 was present in the ®rst intron in both normal tissues and MMs, but protected from EcoRI cleavage in tumors giving rise to the additional 3.5 kb fragment.
Direct sequencing of intron 1 of the wt1 gene from normal liver and mesothelioma cell line II45, which had the extra 3.5 kb EcoRI fragment, revealed no dierences in the sequence of the protected EcoRI (prE) site, which was present in both DNAs. However, the site was¯anked 5' by a C and 3' by a G (Figure  1a) , which created potential sites for cytosine methylation that could make the prE site refractory to enzymatic digestion in MMs.
To demonstrate that the mesothelioma-speci®c EcoRI digestion pattern was due to cytosine methylation of the prE site, cell line II45 was treated with 5-azadeoxycytosine (5-aza-dC) to inhibit cytosine methylation. DNA was isolated from cells grown for 72 h in medium with 2 mM 5-aza-dC, digested with EcoRI and Figure 3 Southern analysis of the wt1 gene from various rat strains. DNA from six dierent strains of laboratory rats was digested with EcoRI and hybridized to a probe for wt1 exon 1 ± 7
wt1 site-specific methylation EV Kleymenova et al hybridized with a wt1 exon 2 probe. After DNA hypomethylation by 5-aza-dC treatment, cell line II45 exhibited the same digestion pattern as normal rat tissues, with a substantial decrease in the 3.5 kb EcoRI fragment and the appearance of the 300 bp fragment ( Figure 5 ), indicating that methylation of the prE site was responsible for the lack of enzymatic digestion at this site in MM DNA.
To determine if methylation of the prE site was a re¯ection of a global increase in DNA methylation in mesothelioma cells we estimated the levels of DNA methylation using the in vitro methyl-accepting assay in DNA from normal rat tissues, cell line II45 (which contained the tumor-speci®c 3.5 kb EcoRI fragment resulting from methylation within prE site) and cell line II14 (which like normal rat tissues, did not exhibit the 3.5 kb EcoRI fragment). As summarized in Table 1 , no dierences were found in methyl-group incorporation into DNA from II14 or II45, indicating that DNA methylation levels were roughly equal in both cell lines. Methyl-group incorporation into DNA from normal tissues was signi®cantly lower than incorporation into tumor DNA, indicating that DNA from the MM cell lines was less methylated than DNA from normal cells. Therefore, the methylation of the prE site in MM was not simply a re¯ection of a global increase in DNA methylation in tumor cells.
To assay methylation of other CpG sites in the 5' region of the wt1 gene Southern analysis of DNA from MM cell lines II14, II45, III2, TO8, ME3 and normal mesothelium was performed using HpaII/MspI digestion and probes for wt1 exons 1 ± 3 and intron 1. HpaII/MspI digestion of DNA from all MM cell lines studied yielded the same pattern as digestion of DNA from normal mesothelium with regard to both methylated and unmethylated CpG sites present in this region of the wt1 gene. Figure 6 shows that wt1, intron 1 unmethylated (1.6 and 0.6 kb bands present in both HpaII and MspI lanes) and methylated (0.8 kb band visible only in HpaII lanes) sites recognized by these isoschizomers were the same in normal mesothelium and MM II45. However, in the 5' region of wt1, methylation at the prE site did not follow this general methylation pattern as normal cells, while methylated at the same sites in wt1 intron 1 as II45 (Figure 6 ), did not display methylation at the prE site seen in mesotheliomas and MM cell lines.
To determine whether methylation of the prE site was speci®c for MM or occurred in other tumors as well, we analysed by Southern analysis the wt1 EcoRI (Walker et al., 1994) , neither ERC ( Figure 7 ) nor ELT cell lines (data not shown) expressed the wt1 gene. However, while the normal EcoRI digestion pattern was observed in primary renal cell carcinomas and ELT cell lines (Figure 8 ), ®ve of seven ERC cell lines exhibited methylation at the prE site as evidenced by 3.5 kb EcoRI band (Figure 8 ), indicating that transformed cells other than mesothelial cells also speci®cally methylated this site, even in the absence of wt1 gene expression.
Discussion
Although mutations in the wt1 gene were not observed in rat mesothelioma cell lines, a CpG site in intron 1 of the wt1 gene was found to be methylated in almost all rat MM, including primary tumors and cell lines, and in most rat RCC cell lines studied. Methylation of this prE site prevented normal cleavage of the wt1 gene by EcoRI and so produced an altered EcoRI digestion pattern of this gene in rat MM and ERC cell lines. Treatment of MM cell line II45, which had the altered EcoRI digestion pattern, with the well established inhibitor of DNA methylation 5-aza-dC restored prE site cleavage, indicating that the altered digestion pattern was caused by methylation of one or both cytosine residues at this site. Sensitivity of EcoRI to cytosine methylation is well known for prokaryotes and has been reported for synthetic oligomers (Brennan et al., 1986) , but not for eukaryotic genomic DNA. The ability of methyl cytosine to alter EcoRI cleavage of genomic DNA in mammals is not generally appreciated, and could cause misinterpretation of Southern analysis data if not considered. Methylation of the prE site in two dierent types of rat tumor cells suggests that a common tumor-speci®c mechanism of DNA methylation may regulate methylation of this site. Prolonged exposure of Southern blots with DNA from normal cells revealed a very low level of methylation at this site in normal DNA suggesting that a quantitative rather than qualitative change in methylation occurs at this site in tumor DNA. A previous study in our laboratory (Walker et al., 1994) demonstrated wt1 expression in normal rat tissues and MM cell line II14, in which the prE site was unmethylated, and in MM cell lines II45, III2, ME1T, and NRM2, in which the prE site was methylated, indicating that transcription of the wt1 gene in rat mesotheliomas is not the primary determinant for methylation at this site. Southern analysis of wt1 5' region revealed presence both methylated and unmethylated CpG sites in wt1 intron 1 in MM indicating that methylation of prE site was not due to hypermethylation of this region. Moreover, methylation of this site does not correlate with methylation of other CpG sites within 5' region of wt1 gene oering unique opportunities for studying determinants of tumor-speci®c methylation. Signi®cant increases in methylation of the prE site observable in both transformed cells that expressed (mesothelioma) and did not express (renal cell carcinoma) wt1 suggests that regardless of wt1 expression tumor cells can speci®cally recognize this site for DNA methylation. Why the prE site is methylated in tumor cells with a high frequency is not clear at present. Our data are consistent with the hypothesis that there are`hot spots' that are preferentially recognized by DNA methyltransferase (Smith et al., 1991) . We identi®ed several consensus sequences for DNA-binding proteins, including transcriptional factors GCN4, SP1 and AP2, and histone H4 in intron 1 of the rat wt1 gene, the H4 binding site being nearest to the prE site (Figure 1a) . Histone H4 is one of the four core histones that pack DNA into nucleosomes, and its absence or modi®cation by deacetylation, for example, results in local chromatin perturbations (Wole, 1994) . Future studies of chromatin structure near prE site in MM and ERC cell lines may shed some light on the cause for its tumor-speci®c methylation. The lack of methylation at the prE site in ELT cell lines, in contrast to MM and ERC cell lines in which this site was frequently methylated, suggests that tissue-speci®c events may also be involved in site-speci®c DNA methylation in tumor cells. Methylation of the prE site in the wt1 gene was detected in a majority of primary mesotheliomas, indicating that methylation at this site is not a cell culture artifact. The extent of tumorspeci®c methylation at the prE site in primary tumors was variable (data not shown), suggesting either tumor heterogeneity exists or re¯ecting the presence of normal cells, such as stromal cells, that do not methylate prE site, in the tumor tissue.
Methylation of the WT1 gene in normal or tumor cells has not been well studied, although human chromosome 11 where the WT gene is located is known to be imprinted and contains genes such as H19 and IGFII whose expression is regulated by DNA methylation (Li et al., 1993) . Methylation of 11p13 region in Wilms' tumors was studied by Royer-Pokora and Schneider (1992) . In that study, CpG methylation in the wt1 5' region was found in two of 29 Wilms' tumors, whereas normal kidney and blood were unmethylated; however, no correlation was observed between methylation and WT1 expression. In addition, several methylated CpG sites 100 kb distal to the WT1 gene and 100 ± 150 kb proximal to WT1 were demethylated in most tumors analysed. Interestingly, Wilms' tumors which were hypomethylated proximal to WT1 expressed high levels of WT1, although a direct link between WT1 methylation and transcription in Wilms' tumors remains to be established. In our study, the 5-aza-dC treatment that restored normal EcoRI cleavage did not change the expression of the wt1 gene in MM cell lines T08 and T10 (data not shown), which were methylated at the prE site and which had been previously shown to express low levels of wt1 (Walker et al., 1994) .
The ability of DNA methylation to regulate gene expression points to an important role for de novo methylation in cell growth and dierentiation. However, how speci®c CpG sites, substrates for DNA methyltransferase, are recognized in mammalian cells, especially tumor cells, remains largely unknown. Our identi®cation of a CpG site frequently methylated in tumors provides a useful model system for studying how malignant cells establish DNA methylation patterns via de novo DNA methylation events at speci®c sites. Future studies using this model system may yield new insights into the mechanisms of de novo methylation in normal and neoplastic cells.
Materials and methods

Cell lines and tumors
The cell lines II14, II45 and III2 were derived from chrysotile-induced rat mesotheliomas (Craighead et al., 1987) . Cell lines T10 and T08 were derived from crocidolite-induced rat mesotheliomas (Palekar et al., 1988) . Cell lines ME1 and ME1T were derived from a spontaneous rat MM (Funaki et al., 1991) . Cell lines NRM1, NRM2, NRM3, and NRM4 are rat pleural mesothelial cells spontaneously transformed in vitro (Bermudez et al., 1990) . Cell lines ERC 15, ERC 17, ERC 18, ERC 19, ERC 21, ERC 24, and ERC 37 were derived from renal cell carcinomas (Freed et al., 1990) and cell lines ELT 3, ELT 4, ELT 5A, ELT 5B, and ELT 6 were derived from leiomyomas/leiomyosarcomas (Howe et al., 1995) ; both of which develop spontaneously in Eker rats. All cell lines were maintained as described by authors. Five chrysotile-induced rat mesotheliomas obtained by installation of Ural-mined milled chrysotile (a single dose of 60 mg per rat) into Wistar rat peritoneal cavities and nine spontaneous renal cell carcinomas from Eker rats were also used.
PCR
Genomic DNA was obtained by phenol-chloroform extraction from cell lines in the log phase of growth and quick-frozen normal tissues and tumors pulverized under liquid nitrogen. The DNA was con®rmed by electrophoresis to be of high molecular weight and was quanti®ed by spectrophotometry. Total RNA was isolated as described (Chirgwin et al., 1979) from cell lines and tissues under conditions mentioned above. Poly(A) + RNA was obtained by oligodeoxythymidylate cellulose anity chromatography. Reverse transcription and PCR of one half of the reverse transcribed product or 0.5 ± 1 mg of DNA were performed under conditions described previously (Kleymenova et al., 1997) . The LA PCR kit from TaKaRa (Pan Vera Corp., Madison, WI) was used according to manufacturer's instructions to amplify a 6 kb fragment of the wt1 gene from exon 1 to exon 3. The primers used to amplify various exons of the rat wt1 gene were based on the rat wt1 sequence published previously (Sharma et al., 1992) , and are shown in Figure 1a . Primers used were: exon 1 ± 10 probe -4581+4887; exon 1 ± 7 probe -4581+4585; exon 4 ± 7 probe -4883+4585; exon 1 ± 3 probe4581+r618; exon 2 probe -T7B + T7. Primers P1, T3A, T3B, T3C, T7A, T7C, T7 and T3 were used for sequencing. Primers T3 and T7 were purchased from Promega Corp., Madison, WI; sequence of other primers is available upon request. The PCR products were electrophoresed on a 1% LMP agarose gel (Gibco BRL, Gaithersburg, MD), and bands of the expected sizes were gel-puri®ed with the Wizard PCR Preps System (Promega Corp., Madison, WI), and used for sequencing or as probes for hybridization.
Southern analysis
Fifteen micrograms of genomic DNA was digested with restriction enzymes under conditions suggested by manufacturer, electrophoresed in 0.8% agarose gel, and denatured with 0.5 M NaOH and 1.5 M NaCl. After neutralization in 1.5 M NaCl and 1 M Tris-HCl, the DNA was transferred to nitrocellulose membranes in 206SSC. The Prime-it Random Primer Labeling kit (Stratagene, La wt1 site-specific methylation EV Kleymenova et al Jolla, CA) was used to label probes for hybridization. Hybridization was performed at 428C in 50% formamide, 56SSC, and 0.25% SDS for 48 h. Blots were washed in 0.16SSC and 0.05% SDS, dried, and exposed to X-ray ®lm with an intensifying screen at 7708C.
DNA cloning
Forty-®ve micrograms of DNA from MM cell line II45 was digested with EcoRI and electrophoresed in a 1% LMP agarose gel. Using a 1 kb DNA Ladder (Gibco BRL, Gaithersburg, MD) stained with ethidium bromide as a reference, 3 ± 4 kb DNA fragments were gel-puri®ed with the Wizard PCR Preps System. A genomic library containing these inserts cloned into the EcoRI site of the vector Lambda ZAP II (Stratagene, La Jolla, CA) was screened by Lark Sequencing Technologies Inc. (Houston, TX). By using a PCR product spanning wt1 exons 1 ± 3 as a probe, positive clones were isolated, and after two rounds of screening, one clone was chosen for pBluescript excision. The pBluescript phagemid containing the cloned insert was excised to generate the phagemid clone wk 1.4.
DNA sequencing
Puri®ed PCR products and clone wk 1.4 were directly sequenced with the fmol DNA Sequencing System kit (Promega Corp., Madison, WI) according to manufacturer's instructions. Sequences were analysed with the Wisconsin Sequence Analysis Package (Genetic Computer Group, Madison, WI).
Methyl-accepting assay
To determine levels of DNA methylation, in vitro methylaccepting assay (Wu et al., 1993) was performed. In this assay DNA methylation levels are inversely related to the incorporation of methyl-groups into DNA. Two hundred nanograms of DNA was treated with 4 units of M.Sss I CpG Methylase (New England Biolabs, Beverly, MA) in the presence of 5 mM [ 3 H]S-adenosylmethionine (SAM) and an equal amount of nonradioactive SAM for 3 h at 378C. Methyl-group incorporation was determined by measuring 3 H c.p.m./ng DNA. All samples were performed in duplicate. Reactions without either DNA or enzyme added served as negative controls.
5-aza-dC treatment
MM cell lines II45, T08, and T10 were plated in appropriate medium in 150 mm dishes at low density (15% con¯uence) and allowed to proliferate for 24 h. The medium was then removed and replaced with medium containing 2 mM 5-aza-dC (Sigma Chemical Co., St. Louis, MO) prepared immediately before use. The cells were grown for 96 h (75 ± 85% con¯uence) in the presence of 5-aza-dC, and DNA was obtained by Qiagen kit (Qiagen Inc., Chatsworth, CA).
